The Truth About Stem Cells

Learn what you and your patients need to know about stem cell treatments for retinal diseases

By Susan L. Worley, contributing writer

Allergan Seeks Durable Response in Phase 3 DARPin Trial

New Monoclonal Antibody Treatments in Retina

An alphabet soup with potential to preserve vision.

Identifying the Genetic Mutation for North Carolina Macular Dystrophy

My path on the road to mutation.

The Cost-Effectiveness of Anti-VEGF Treatment in Diabetes

It’s hard to put a price on letters and lines.

Management of Anti-VEGF Inventory

Careful planning avoids unnecessary costs.

Anti-VEGF for Non-AMD Causes of Choroidal Neovascularization

Proven benefits for a variety of etiologies.

Update on the Diagnosis and Management of Pediatric Retinal Disease: Precision Medicine

Part 3 of a 3-part series on non-ROP pediatric retinal conditions.

Practical Applications of Endoscopic Vitrectomy for the Vitreoretinal Surgeon

Overcome the learning curve to bypass opacities.

Clinical Pearls for Iluvien Use for DME

When and how to use the sustained-release corticosteroid implant.

UPFRONT: Thinking Different to Preserve Vision

SUBSPECIALTY NEWS

By Jerry Helzner, contributing editor

CODING Q&A: Of Diagnostic Tests and Documentation

RETINA CONVERSATIONS: A Conversation With Paul A. Yates, MD, PhD

CLINICAL TRIAL UPDATE

NEW PRODUCT APPLICATIONS: Retinal Forceps Are Durable, Convenient, and Economical

The Growing Emphasis on Genetics in Retinal Disease

New initiatives focus on key role of genetic factors

The Expanding Role of OCT Angiography

Experts discuss when and how to best utilize this technology

CODING CORNER

5 Key Reimbursement Pearls